Cargando…
P31 Impact of COVID-19 on HTA/PRMA of Medicinal Products in Europe: A Payer Perspective
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Elsevier Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8769652/ http://dx.doi.org/10.1016/j.jval.2021.11.030 |
| _version_ | 1784635197368565760 |
|---|---|
| author | Mycka, J Dellamano, R Lobb, W Dalal, N Dellamano, L Pereira, E |
| author_facet | Mycka, J Dellamano, R Lobb, W Dalal, N Dellamano, L Pereira, E |
| author_sort | Mycka, J |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8769652 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-87696522022-01-20 P31 Impact of COVID-19 on HTA/PRMA of Medicinal Products in Europe: A Payer Perspective Mycka, J Dellamano, R Lobb, W Dalal, N Dellamano, L Pereira, E Value Health Article Published by Elsevier Inc. 2022-01 2022-01-19 /pmc/articles/PMC8769652/ http://dx.doi.org/10.1016/j.jval.2021.11.030 Text en Copyright © 2021 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Mycka, J Dellamano, R Lobb, W Dalal, N Dellamano, L Pereira, E P31 Impact of COVID-19 on HTA/PRMA of Medicinal Products in Europe: A Payer Perspective |
| title | P31 Impact of COVID-19 on HTA/PRMA of Medicinal Products in Europe: A Payer Perspective |
| title_full | P31 Impact of COVID-19 on HTA/PRMA of Medicinal Products in Europe: A Payer Perspective |
| title_fullStr | P31 Impact of COVID-19 on HTA/PRMA of Medicinal Products in Europe: A Payer Perspective |
| title_full_unstemmed | P31 Impact of COVID-19 on HTA/PRMA of Medicinal Products in Europe: A Payer Perspective |
| title_short | P31 Impact of COVID-19 on HTA/PRMA of Medicinal Products in Europe: A Payer Perspective |
| title_sort | p31 impact of covid-19 on hta/prma of medicinal products in europe: a payer perspective |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8769652/ http://dx.doi.org/10.1016/j.jval.2021.11.030 |
| work_keys_str_mv | AT myckaj p31impactofcovid19onhtaprmaofmedicinalproductsineuropeapayerperspective AT dellamanor p31impactofcovid19onhtaprmaofmedicinalproductsineuropeapayerperspective AT lobbw p31impactofcovid19onhtaprmaofmedicinalproductsineuropeapayerperspective AT dalaln p31impactofcovid19onhtaprmaofmedicinalproductsineuropeapayerperspective AT dellamanol p31impactofcovid19onhtaprmaofmedicinalproductsineuropeapayerperspective AT pereirae p31impactofcovid19onhtaprmaofmedicinalproductsineuropeapayerperspective |